| Tiffany Lee Petersen, | |
|
2116 Craig Rd, Eau Claire, WI 54701-6118 | |
| (715) 858-4500 | |
| Not Available |
| Full Name | Tiffany Lee Petersen |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 2116 Craig Rd, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861169716 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marshfield Medical Center - Eau Claire | Eau claire, WI | Hospital |
| Sacred Heart Hospital | Eau claire, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mchs Hospitals Inc | 5698071173 | 1049 |
| North American Partners In Anesthesia Wisconsin Sc | 8729475447 | 27 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
| Entity Name | Tri-county Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124063573 PECOS PAC ID: 4587642418 Enrollment ID: O20040708000696 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
| Entity Name | Independent Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1922316835 PECOS PAC ID: 8527249002 Enrollment ID: O20110217000285 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
| Entity Name | North American Partners In Anesthesia Wisconsin Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720733454 PECOS PAC ID: 8729475447 Enrollment ID: O20220428000422 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Lee Petersen, 2116 Craig Rd, Eau Claire, WI 54701-6118 Ph: () - | Tiffany Lee Petersen, 2116 Craig Rd, Eau Claire, WI 54701-6118 Ph: (715) 858-4500 |
News Archive
Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.
On September 19 a number of organizations are joining in briefings on health care reform that would really allow health care to become more affordable and more responsive to the individual rights and choices of Americans. This will provide a stark contrast to the many contradictory and expensive proposals that are now under consideration in Congress.
For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy and delivery would be too difficult for them, and that they should not have babies.
Researchers have examined what's currently known about the neuroendocrine effects of grief and whether biological factors can predict complicated or prolonged grief after the death of a loved one. The findings appear in the journal of Neuroendocrinology
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
› Verified 8 days ago
Kathy L Mcnally, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
Kimberly S Mertens, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
Jean J Jasienski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Seth E Bollinger, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2116 Craig Rd, Eau Claire, WI 54701 Phone: 715-858-4500 | |
Andrea J Anderson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
Tasha Jo Hay, DNAP, ARPN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Shelley L Kadlec, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 |